Organization, Plan of Business Operations (Details) - USD ($) $ / shares in Units, $ in Thousands |
6 Months Ended | |||
|---|---|---|---|---|
Feb. 08, 2019 |
Jun. 30, 2021 |
Dec. 31, 2020 |
Nov. 12, 2018 |
|
| Accumulated deficit | $ 75,215 | $ 73,268 | ||
| Cash and cash equivalents | 1,121 | $ 3,132 | ||
| Contractual milestone payments | $ 5,000 | |||
| Line of Credit [Member] | ||||
| Interim Financing Amount | $ 7,000 | |||
| Invagen Pharmaceuticals Inc [Member] | ||||
| Business Acquisition, Equity Interest Issued or Issuable, Value Assigned | $ 35,000 | |||
| Percentage of equity interest agreed to acquire in first stage | 33.30% | |||
| Business Acquisition, Equity Interest Issued or Issuable, Value Assigned, Remaining Purchase Amount | $ 180,000 | |||
| Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | 5,833,333 | |||
| Business Acquisition, Share Price | $ 6.00 | |||
| Business acquisition shares acquisition for net proceeds | $ 31,500 | |||
| Invagen Pharmaceuticals Inc [Member] | Invagen Pharmaceuticals Inc [Member] | ||||
| Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | 33.30% |
| X | ||||||||||
- Definition Net proceeds paid for equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity. No definition available.
|
| X | ||||||||||
- Definition Business Acquisition, Equity Interest Issued or Issuable, Value Assigned, Remaining Purchase Amount No definition available.
|
| X | ||||||||||
- Definition Percentage of voting equity interests agreed to acquire at the acquisition date in the business combination. No definition available.
|
| X | ||||||||||
- Definition Represents the information pertaining to Contractual milestone payments. No definition available.
|
| X | ||||||||||
- Definition Amount of interim financing receivable. No definition available.
|
| X | ||||||||||
- Definition Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination. No definition available.
|
| X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity. No definition available.
|
| X | ||||||||||
- Definition The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|